twistbioscience.com - TWST Income before deduction of interest, taxes and amortization
Geopolitical fractures and sanctions are hindering the export of Twist Bioscience (TWST) equipment, slowing down scientific research. However, absolute EBITDA is growing due to the implementation of unique silicon-based DNA printing and a strategic alliance with Big Pharma for antibody development. This chart indicates capacity expansion, while the 0.00 metric serves as the target level for current operating profit.
Summary analytical data breakdowns for Twist Bioscience, Inc. (TWST)
- current price and projected stock value:
- issuer market value details:
- book capitalization information:
- business debt structure and liquidity details:
Debt to Capital Twist Bioscience|TWST - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Twist Bioscience Inc|TWST - Company Aggregate Debts|Debt to Book Value Twist Bioscience|TWST - Company Long-Term Debts|Short-Term Debt Volume Twist Bioscience|Immediate Liquidity twistbioscience.com
- net income and valuation multiples indicators:
TWST - Company Net Income|Net Profit Forecast Twist Bioscience|TWST - P/E Multiple|Projected Price to Earnings twistbioscience.com|TWST - PEG Multiple|Company Value to EBITDA Twist Bioscience|TWST - Operating profit before deduction of amortization|Earnings per share for the last four quarters Twist Bioscience|TWST - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months twistbioscience.com|TWST - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Twist Bioscience
Summary company analytics:TWST - Twist Bioscience Corp
The indicator is calculated as earnings before interest, taxes, depreciation, and amortization, reflecting the net cash flow from core operations. This metric measures the internal efficiency of the business, excluding the impact of debt load and accounting write-offs. For Twist Bioscience (TWST), growth in this value confirms the high profitability of robotic synthetic DNA production. However, the EBITDA trajectory often becomes a point of conflict between buyer optimism and seller concerns. The resulting price action determines the company's future cost of capital.
Who Twist Bioscience competes with
Company profit before taxes, interest and amortization TEM (Tempus)|QGEN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization IONS (ionispharma.com)|RGEN: Operating profit EBITDA|RNA (Avidity Biosciences Inc) - Profit before payment of interest, taxes and amortization|CRSP (CRISPR Therapeutics Corp) - Operating profit EBITDA|GeneDx Corp (WGS) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Ultragenyx Pharmaceutical (RARE)|BEAM - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Sarepta SRPT|Operating income before deduction of amortization 10x Genomics Inc (TXG)|Intellia - Operating profit EBITDA|Stoke Corp (STOK) - Operating profit before deduction of amortization|BLFS: Operating profit EBITDA|WVE - Operating income before deduction of amortization|MAZE (Maze Therapeutics) - Operating profit EBITDA|Profit before interest, taxes and amortization Sionna Therapeutics, Inc. SION|Profit before payment of interest, taxes and amortization Prime Medicine Corp (PRME)|Taysha Corp - Operating profit before amortization|Operating profit EBITDA QURE (uniQure N.V.)|MGTX - Operating profit before deduction of amortization|REGENXBIO - Operating profit EBITDA|Profit before interest, taxes and amortization Solid Biosciences Inc|OCGN (Ocugen Corp) - Operating profit before deduction of amortization|PACB: Company profit before taxes, interest and amortization|Operating profit before deduction of amortization BNTC|Operating profit before deduction of amortization designtx.com (DSGN)|Profit before payment of interest, taxes and amortization Rocket Pharmaceuticals, Inc. (RCKT)|Operating income before deduction of amortization 4DMT|Lexeo Therapeutics, Inc. - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization KRRO (Korro Bio Inc.)|Editas Medicine, Inc. - Operating profit EBITDA|SLN (silence-therapeutics.com) - Operating profit before amortization|proqr.com (PRQR) - Profit before payment of interest, taxes and amortization|Operating profit before amortization CDXS|SGMO (Sangamo) - Operating profit EBITDA|Operating profit EBITDA Nautilus Biotechnology Inc|Operating profit before deduction of amortization MGX (Metagenomi, Inc.)|Company profit before taxes, interest and amortization DTIL|Generation Bio - Operating profit before deduction of amortization|BOLD - Operating profit before deduction of amortization|Exicure Corp - Operating profit EBITDA|Operating income before deduction of amortization Imunon, Inc. IMNN|phiopharma.com (PHIO) - Profit before payment of interest, taxes and amortization|MBIO - Operating income before deduction of amortization|Operating profit before deduction of amortization RNAZ|BNGO (Bionano) - Company profit before taxes, interest and amortization|Operating profit before deduction of amortization APDN (Applied DNA)|BLUE (bluebird bio, Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA IPA (ImmunoPrecise Antibodies Ltd.)|omegatherapeutics.com - Profit before payment of interest, taxes and amortization|Singular Genomics - Operating profit EBITDA|Operating income before deduction of amortization Regulus Therapeutics, Inc. RGLS|Syros (SYRS) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Telesis Bio, Inc (TBIO)|Profit before payment of interest, taxes and amortization TRACON Pharmaceuticals|unitybiotechnology.com (UBX) - Operating income before deduction of amortization
